These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4820014)

  • 21. Estriol-induced fibrinolysis due to the activation of plasminogen to plasmin by nitric oxide synthesis in platelets.
    Jana P; Maiti S; Kahn NN; Sinha AK
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):316-23. PubMed ID: 24695088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological properties of 1-desamino-8-lysine-vasopressin.
    KIMBROUGH RD; CASH WD; BRANDA LA; CHAN WY; DU VIGNEAUD V
    J Biol Chem; 1963 Apr; 238():1411-4. PubMed ID: 14032722
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease.
    Pedersen OD; Gram J; Jespersen J
    Thromb Haemost; 1995 May; 73(5):835-40. PubMed ID: 7482412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of pharmacological effects of lysine and arginine vasopressins.
    VAN DYKE HB; ENGEL SL; ADAMSONS K
    Proc Soc Exp Biol Med; 1956 Mar; 91(3):484-6. PubMed ID: 13322973
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects.
    MacGregor IR; Roberts EM; Prowse CV; Broomhead AF; Ozolins M; Litka P
    Thromb Haemost; 1988 Feb; 59(1):34-9. PubMed ID: 3129807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino-acids and peptides. 23. The synthesis of peptides related to arginine-vasopressin.
    Cox ME; Garg HG; Hollowood J; Hugo JM; Scopes PM; Young GT
    J Chem Soc Perkin 1; 1965 Dec; ():6806-13. PubMed ID: 5892021
    [No Abstract]   [Full Text] [Related]  

  • 27. Activation of plasma prorenin by plasminogen activators in vitro and increase in plasma renin after stimulation of fibrinolytic activity in vivo.
    Derkx FH; Brommer EJ; Boomsma F; Schalekamp MA
    Neth J Med; 1984; 27(4):124-8. PubMed ID: 6377102
    [No Abstract]   [Full Text] [Related]  

  • 28. [Synthesis of ala-1-ala-6-arg-8-vasopressins and ala-1-ala-6-lys-8-vasopressins as well as (desamino-ala)-1-ala-6-arg-8-vasopressins and (desamino-ala)-1-ala-6-lys-8-vasopressins].
    Huguenin RL; Guttmann S
    Helv Chim Acta; 1965 Dec; 48(8):1885-98. PubMed ID: 5848007
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of dexamethasone on ACTH release induced by lysine vasopressin in man; time interval between dexamethasone and vasopressin injection.
    Takebe K; Kunita H; Sakakura M; Horiuchi Y
    J Clin Endocrinol Metab; 1968 May; 28(5):644-50. PubMed ID: 4297476
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
    Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure--activity relations of the fibrinolytic response to vasopressins in man.
    Cash JD; Gader AM; Mulder JL; Cort JH
    Clin Sci Mol Med; 1978 Apr; 54(4):403-9. PubMed ID: 639471
    [No Abstract]   [Full Text] [Related]  

  • 32. ON THE CONFIGURATION OF A LYSINE -VASOPRESSIN DIMER.
    SCHALLY AV; BARRETT JF
    J Am Chem Soc; 1965 Jun; 87():2497-9. PubMed ID: 14327158
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of 1-desamino-8-D-arginine-vasopressin in limited renal function].
    Scheitza E
    Arzneimittelforschung; 1975 Feb; 25(2):260-2. PubMed ID: 1173046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidiuretic action of 1-deamino-(8-D-arginine)-vasopressin in unanesthetized rats.
    Vávra I; Machová A; Krejcí I
    J Pharmacol Exp Ther; 1974 Jan; 188(1):241-7. PubMed ID: 4809272
    [No Abstract]   [Full Text] [Related]  

  • 35. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of vasopressin and its analogs on blood coagulation in rats].
    Golubeva MG; Kalishevskaia TM; Solov'eva ME
    Fiziol Zh (1978); 1990; 36(3):25-30. PubMed ID: 2394244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidiuretic hormone and lipolysis.
    Bartsokas K; Polychronopoulou-Trichopolou A; Kouvelas ED; Charissiadou A; Valsamakis S; Kalaitzidou C
    Endokrinologie; 1975 Jan; 64(2):201-4. PubMed ID: 1149694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus.
    Vicari AM; Viganó D'Angelo S; Testa S; Comi G; Galardi G; Orsi E; D'Angelo A
    Horm Metab Res; 1992 Nov; 24(11):516-9. PubMed ID: 1452117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A new synthetic analog of vasopressin, desamino-6 carba-(8-D-arginin)-vasopressin, active against diabetes insipidus refractory to vasopressin and adiuretin spofa (author's transl)].
    Schück O; Cort JH; Stríbrná J; Skopková J; Jost K
    Cas Lek Cesk; 1975 Feb; 114(6):172-5. PubMed ID: 1092463
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experiences with the synthetic vasopressin derivative 1-desamino-8-D-arginine vasopressin (DDAVP) in the therapy of diabetes insipidus].
    Schrader D; Frahm H; Freisenhausen HD; Lüdecke D; Krüger HP
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1909-12. PubMed ID: 1030134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.